Ozempic

Danish maker of obesity drugs to replace Lars Fruergaard Jørgensen, saying new leadership is needed

Medicine shortages increasingly negatively affecting patient outcomes, Irish Pharmacy Union says

First-quarter sales rise 18 per cent but Danish pharma group blames custom preparations at pharmacies for weaker take-up

Prof Donal O’Shea hails breakthrough and says it may play key role in reshaping treatments

Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients

Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now at least

Pharma companies ‘disappointed’ in Government’s stance during EU negotiations

Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year

Radio: The whiff of cordite in the RTÉ studio is strong enough to warrant a UN peacekeeping mandate of its own

Danish obesity drug giant looking at whether its semaglutide drug can reduce cravings associated with addiction

Television: In her new RTÉ documentary the presenter takes a very personal approach to weight-loss drugs

Glanbia's once-popular weight-loss product has fallen out of favour with consumers

The World Anti-Doping Agency has added the active ingredient semaglutide to its watch-list for 2025

Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately

Seen & heard: Developers summoned; Xerotech on the brink; Glencore eyes Pallas Green sale; CRH invests in 3D; Mounjaro arrives; and O’Hara brewery talks

Doctors followed protocol regarding weight-loss drug, says coroner

From rows about staffing, waiting lists and cost overruns to resignations of senior staff, heathcare was never far from the news headlines in 2024

Much hype surrounds drugs called GLP-1 agonists but they are intended for diabetes patients and people who are obese, not those who just want to lose a few pounds

RTÉ Investigates programme to be aired on Monday examines illegitimate sales of weight loss drugs, despite some being labelled as ‘not for human use’

Companies competing for leadership in fast-growing market where supply continues to be an issue

HPRA warns of risks of illegal, counterfeit versions of drugs such as Ozempic and Wegovy, saying they pose ‘significant risk’

Appointment would put Kennedy, who sowed doubts about Covid-19 vaccines, in charge of a department with a $1.8 trillion budget

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use

Drastic action is considered essential, but this is part of a wider strategy that represents a looming calamity for Stormont

Actor (61) plays a has-been celebrity who is tempted by a youth serum in hyperreal film The Substance

Using such medications to lose excess fat that risks your health is no more of a moral failing than using a blood pressure medication to lower high blood pressure that increases your risk of stroke

The new generation of weight loss medications have revolutionised the treatment of obesity. But reports of an unexpected side effect - surprise pregnancies - have led to questions about why this is happening

Seen & Heard: Inheritance tax reduction, Press Up stake and Spar sale

Officials warned consumers of risks from falsified versions of Ozempic and Wegovy

The new brand, Vital Pursuit, is set to hit supermarket shelves in the US this October

News of new factory comes after Danish group announced in December the purchase of drug manufacturing plant in Athlone in order to keep up with demand for weight-loss drugs

Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments

Proposals would lower time period a company has protection over research behind drugs they develop

The senator on living alone, destigmatising homosexuality, and stepping down from politics

Concerns about weight-loss drugs hurting sales are ‘overblown’ say Citi analysts but investors are worried

Correspondence between health officials details 'high level of concern' about obesity drug shortages

Television: Presenter Anna Richardson explores how drugs like Ozempic and Wegovy work and the potential side effects

Company boosted by trial results showing weight loss drug also cuts risk of heart attack by 20%

Novo Nordisk profits surging due to huge demand for obesity drugs Ozempic and Wegovy

Danish drugmaker pushing for US and EU approval but has struggled to meet demand for its Ozempic and Wegovy drugs